Delta Biosciences

Delta Biosciences is an innovative European biotech leveraging high-throughput technology for molecular discovery in both medicine and the emerging field of astrochemistry. Founded in 2018 and based in London, the company's core mission is to accelerate the design, testing, and evolution of chemical compounds. While details on specific programs are limited from the provided data, its positioning suggests a platform technology company with a highly differentiated focus on space-enabled chemistry. The company appears to be a private, early-stage venture, likely pre-revenue and in a platform development or pre-clinical stage.

Next-generation high-throughput technology for the design, testing, and evolution of chemical compounds, integrated with astrochemistry (space-based) experimentation capabilities.

Competes with numerous well-funded biotech platforms using AI and automation for drug discovery. Its astrochemistry focus is a key differentiator but places it in a nascent, unproven market segment with few direct competitors, though it faces competition for space-based research resources and partnerships.